CHIEF: A retrospective self-control study of children with severe hemophilia A without inhibitors comparing emicizumab to FVIII prophylaxis
Bleeding disorders are broadly classified into primary and secondary hemostatic defects
(Fig. 1).
Pediatr Clin N Am 60
